ArticleHuman vaccines & immunotherapeutics2024

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy.

Yue Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.